Search

James Schultz

Examiner (ID: 14322, Phone: (571)272-0763 , Office: P/1633 )

Most Active Art Unit
1633
Art Unit(s)
1633, 1631, 1635
Total Applications
977
Issued Applications
385
Pending Applications
182
Abandoned Applications
415

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5458250 [patent_doc_number] => 20090258402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'L-Glutamic Acid Producing Bacterium and a Method for Production of L-Glutamic Acid' [patent_app_type] => utility [patent_app_number] => 12/034101 [patent_app_country] => US [patent_app_date] => 2008-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8310 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258402.pdf [firstpage_image] =>[orig_patent_app_number] => 12034101 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/034101
L-glutamic acid producing bacterium and a method for production of L-glutamic acid Feb 19, 2008 Issued
Array ( [id] => 6529893 [patent_doc_number] => 20100015218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALLY ACTIVE MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/526869 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 109173 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015218.pdf [firstpage_image] =>[orig_patent_app_number] => 12526869 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/526869
COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALLY ACTIVE MOLECULES Feb 14, 2008 Abandoned
Array ( [id] => 4820296 [patent_doc_number] => 20080226595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/030161 [patent_app_country] => US [patent_app_date] => 2008-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 48769 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226595.pdf [firstpage_image] =>[orig_patent_app_number] => 12030161 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/030161
Treatment of inflammatory diseases using placental stem cells Feb 11, 2008 Issued
Array ( [id] => 6413627 [patent_doc_number] => 20100166842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'AMPHIPHILIC SUBSTANCES AND FUNCTIONALIZED LIPID VESICLES INCLUDING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/523443 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9191 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166842.pdf [firstpage_image] =>[orig_patent_app_number] => 12523443 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/523443
Amphiphilic substances and functionalized lipid vesicles including the same Jan 15, 2008 Issued
Array ( [id] => 6320311 [patent_doc_number] => 20100196338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/522714 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11549 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196338.pdf [firstpage_image] =>[orig_patent_app_number] => 12522714 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/522714
COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE Jan 9, 2008 Abandoned
Array ( [id] => 7800851 [patent_doc_number] => 08129121 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/448840 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 21 [patent_no_of_words] => 10884 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129121.pdf [firstpage_image] =>[orig_patent_app_number] => 12448840 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/448840
Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof Jan 7, 2008 Issued
Array ( [id] => 6159722 [patent_doc_number] => 20110159020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/518061 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 6668 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159020.pdf [firstpage_image] =>[orig_patent_app_number] => 12518061 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/518061
Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof Dec 6, 2007 Abandoned
Array ( [id] => 4826716 [patent_doc_number] => 20080229437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Intergeneric bivalve shellfish hybrid and method for producing' [patent_app_type] => utility [patent_app_number] => 11/986317 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5767 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20080229437.pdf [firstpage_image] =>[orig_patent_app_number] => 11986317 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/986317
Intergeneric bivalve shellfish hybrid and method for producing Nov 19, 2007 Abandoned
Array ( [id] => 4903517 [patent_doc_number] => 20080112930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Methods of treating restenosis' [patent_app_type] => utility [patent_app_number] => 11/982883 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13726 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112930.pdf [firstpage_image] =>[orig_patent_app_number] => 11982883 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/982883
Methods of treating restenosis Nov 5, 2007 Abandoned
Array ( [id] => 5422881 [patent_doc_number] => 20090149336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Indexed library of cells containing genomic modifications and methods of making and utilizing the same' [patent_app_type] => utility [patent_app_number] => 11/978961 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12815 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149336.pdf [firstpage_image] =>[orig_patent_app_number] => 11978961 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/978961
Indexed library of cells containing genomic modifications and methods of making and utilizing the same Oct 28, 2007 Abandoned
Array ( [id] => 9427109 [patent_doc_number] => 08703180 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-04-22 [patent_title] => 'Multiple growth factor compositions, methods of fabrication, and methods of treatment' [patent_app_type] => utility [patent_app_number] => 11/877635 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7484 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11877635 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/877635
Multiple growth factor compositions, methods of fabrication, and methods of treatment Oct 22, 2007 Issued
Array ( [id] => 5428169 [patent_doc_number] => 20090087479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'Orally bioavailable lipid-based constructs' [patent_app_type] => utility [patent_app_number] => 11/904937 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11857 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087479.pdf [firstpage_image] =>[orig_patent_app_number] => 11904937 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/904937
Orally bioavailable lipid-based constructs Sep 27, 2007 Issued
Array ( [id] => 6483903 [patent_doc_number] => 20100008977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'LIPOSOMALLY ENCAPSULATED HYBRID ADENOVIRUS-SEMLIKI FOREST VIRUS (SFV) VECTORS CARRYING RNAI CONSTRUCTS AND THERAPEUTIC GENES FOR USE AGAINST CANCER TARGETS AND OTHER DISEASES' [patent_app_type] => utility [patent_app_number] => 12/439636 [patent_app_country] => US [patent_app_date] => 2007-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9305 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008977.pdf [firstpage_image] =>[orig_patent_app_number] => 12439636 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/439636
LIPOSOMALLY ENCAPSULATED HYBRID ADENOVIRUS-SEMLIKI FOREST VIRUS (SFV) VECTORS CARRYING RNAI CONSTRUCTS AND THERAPEUTIC GENES FOR USE AGAINST CANCER TARGETS AND OTHER DISEASES Sep 2, 2007 Abandoned
Array ( [id] => 5446910 [patent_doc_number] => 20090048136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'KAPPA-CARRAGEENASE AND KAPPA-CARRAGEENASE-CONTAINING COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 11/838884 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14514 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048136.pdf [firstpage_image] =>[orig_patent_app_number] => 11838884 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/838884
KAPPA-CARRAGEENASE AND KAPPA-CARRAGEENASE-CONTAINING COMPOSITIONS Aug 14, 2007 Abandoned
Array ( [id] => 5507964 [patent_doc_number] => 20090081171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Cell system for alleviating syndromes of Parkinson\'s disease in a mammal' [patent_app_type] => utility [patent_app_number] => 11/891935 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13153 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081171.pdf [firstpage_image] =>[orig_patent_app_number] => 11891935 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/891935
Cell system for alleviating syndromes of Parkinson's disease in a mammal Aug 12, 2007 Abandoned
Array ( [id] => 11611535 [patent_doc_number] => 09649379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 12/452825 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 7177 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12452825 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/452825
Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma Jul 24, 2007 Issued
Array ( [id] => 102660 [patent_doc_number] => 07723316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases' [patent_app_type] => utility [patent_app_number] => 11/824426 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20293 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723316.pdf [firstpage_image] =>[orig_patent_app_number] => 11824426 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/824426
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Jun 28, 2007 Issued
Array ( [id] => 5570400 [patent_doc_number] => 20090253778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'DNA composition against tumor stromal antigen FAP and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/820823 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12432 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253778.pdf [firstpage_image] =>[orig_patent_app_number] => 11820823 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/820823
DNA composition against tumor stromal antigen FAP and methods of use thereof Jun 20, 2007 Abandoned
Array ( [id] => 5323017 [patent_doc_number] => 20090061007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Pharmaceutical preparation' [patent_app_type] => utility [patent_app_number] => 11/812459 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11896 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061007.pdf [firstpage_image] =>[orig_patent_app_number] => 11812459 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/812459
Pharmaceutical preparation Jun 18, 2007 Issued
Array ( [id] => 6453578 [patent_doc_number] => 20100154072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'siRNA Kinase and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/302583 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13497 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20100154072.pdf [firstpage_image] =>[orig_patent_app_number] => 12302583 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/302583
siRNA Kinase and Methods of Use May 28, 2007 Abandoned
Menu